Posts Tagged ‘GLP-1’

Taming Problematic Desires for Alcohol as Well as Food

July 11, 2023 — The emergence of advanced medicines for obesity is teaching us a lot about the overlapping mechanisms that drive desires for alcohol, food, and more. Desire, it seems, is more than just a feeling. It is the product of biological processes that our bodies regulate. But those processes can clearly go astray, and desire for food, […]

More Options & Better Outcomes for Obesity Medicine?

October 9, 2018 — Tuesday is obesity medicine day for National Obesity Care Week. And it just so happens that we have two new studies on the subject in the Lancet. They point to a trend. Day by day, we see evidence of more options and better outcomes for medical obesity care. A New Dual-Receptor Agonist Juan Frias and […]

Being Different in Diabetes and Obesity

December 11, 2015 — Being different can be uncomfortable and, sometimes, rewarding. A new review in the Annals of Internal Medicine finds only small differences between a rising crop of new, once-weekly drugs for diabetes called GLP-1 agonists. The investigators found a lot of similarities between the outcomes with these drugs, along with some differences in side effects, body weight, […]

Liraglutide and Heart Disease

November 10, 2015 — If you thought that the onslaught of new studies was done with the closing of ObesityWeek on Friday, think again. Now we have two important new studies of liraglutide and heart disease that were presented at the Annual Scientific Sessions of the American Heart Association (AHA) on Sunday and Monday. The study that’s hogging all the […]